Connection

Jörg Timm to Randomized Controlled Trials as Topic

Back to Details
This is a "connection" page, showing publications Jörg Timm has written about Randomized Controlled Trials as Topic.
Jörg Timm
Connection Strength
0.014
Randomized Controlled Trials as Topic
  1. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021 May 17; 22(1):343.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.